Zum Hauptinhalt springen

Fachartikel

31. Oktober 2022 | Fachartikel

Substance Use Among Residents of Homeless Shelters During the COVID-19 Pandemic: Findings From France.

Substance Use Among Residents of Homeless Shelters During the COVID-19 Pandemic: Findings From France. Scarlett H, Melchior M, Davisse-Paturet C, Aarbaoui TE, Longchamps C, Figueiredo N, Ducarroz S. Int J Public Health. 2022 Aug 25;67…

10. Oktober 2022 | Fachartikel

Addiction in the time of COVID-19: Longitudinal course of substance use, psychological distress, and loneliness among a transnational Tyrolean sample with substance use disorders.

Addiction in the time of COVID-19: Longitudinal course of substance use, psychological distress, and loneliness among a transnational Tyrolean sample with substance use disorders. Lommer K, Schurr T, Frajo-Apor B, Plattner B, Chernova A, Conc…

10. Oktober 2022 | Fachartikel

Analysis of Substance Use Disorder Treatment Admissions in the US by Sex and Race and Ethnicity Before and During the COVID-19 Pandemic.

Analysis of Substance Use Disorder Treatment Admissions in the US by Sex and Race and Ethnicity Before and During the COVID-19 Pandemic. Cantor JH, Whaley CM, Stein BD, Powell D. JAMA Netw Open. 2022;5(9):e2232795. doi:10.1001/jam…

10. Oktober 2022 | Fachartikel

12-step groups during the Covid-19 pandemic: A patient's perspective.

12-step groups during the Covid-19 pandemic: A patient's perspective. Di Carlo F, Alessi MC, Picutti E, Pettorruso M, Martinotti G, di Giannantonio M. Online Emerg Trends Drugs Addict Health. 2022;2:100047. doi: 10.1016/j.etdah.2022.10…

10. Oktober 2022 | Fachartikel

Paxlovid: Wechselwirkungen und Kontraindikationen

Paxlovid: Wechselwirkungen und Kontraindikationen Berlin - Mit Lagevrio (Molnupiravir, Merck Sharp & Dohme) und Paxlovid (Nirmatrelvir, Ritonavir, Pfizer) stehen seit kurzem zwei neue Arzneimittel zur Behandlung von Covid-19 zur Verf…

10. Oktober 2022 | Fachartikel

BfArM. Fachinformation Paxlovid/Ritonavir

BfArM. Fachinformation Paxlovid/Ritonavir Dieses Arzneimittel unterliegt einer zusätzlichen Überwachung. Dies ermöglicht eine schnelle Identifizierung neuer Erkenntnisse über die Sicherheit. Angehörige von Gesundheitsberufen sind aufgefordert…

10. Oktober 2022 | Fachartikel

The Lancet Voice: Anthony Fauci on COVID-19, scientific communication, and the future

The Lancet Voice: Anthony Fauci on COVID-19, scientific communication, and the future October 06, 2022, The Lancet Season 3, Episode 20, Audio, 29:50) https://thelancetvoice.buzzsprout.com/861868/11442974

Weitere Beiträge ansehen

Weitere
akutelle Informationen
zu den Themengebieten